Alithea Genomics MERCURIUS Total DRUG-seq transcriptome profiling library preparation kit

Alithea Genomics has launched MERCURIUS Total DRUG-seq — an extraction-free, full-length transcriptome profiling library preparation kit designed to push the boundaries of high-throughput drug screens, toxicology screens and target validation by enabling the creation of large-scale data generation for machine learning and AI.

Building on the MERCURIUS 3’ DRUG-seq, MERCURIUS Total DRUG-seq captures the complete transcriptome — including lncRNAs and other non-coding RNAs — with greater sensitivity, full-length coverage and high multiplexing capacity, enabling researchers to screen over 50,000 samples.

The product is available in 96-well (1000–25,000 cells) and 384-well (500–10,000 cells) formats and features a streamlined, extraction-free protocol that delivers fast turnaround and low input requirements, without sacrificing scalability or reproducibility. It is available to order as a standalone kit or as part of Alithea’s in-house services.